Main content

    Gastroenterology and Interventional Endoscopy Clinical Trials

    Gastroenterology ServicesOpens new window | Interventional Endoscopy ServicesOpens new window

    Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at ClinicalTrials.gov


    Gastroparesis / Gastric Motility  |  Barrett's Esophagus


    Active Trials

    Gastroparesis / Gastric Motility

    Title: GpR 2: Continuation of the NIDDK Gastroparesis Registry for the Characterization and Clinical Course of Gastroparesis Patients
    Decscription: The Gastroparesis Registry (GpR) is a study to clarify the epidemiology, natural history, clinical course, and other outcomes of gastroparesis.
    Investigator: William Snape, MD
    Eligibility: Subjects aged 18 to 70 y/o with gastroparesis
    Status: Active and open to enrollment
    Contact: Candice Lee, 415-600-1155, Email: LeeCL@cpmcri.org about Study Gastroparesis Registry

    Title: Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
    Decscription: Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial (APRON)
    Investigator: William Snape, MD
    Eligibility: Subjects with nausea and vomiting presumed to be of gastric origin
    Status: Active and open to enrollment
    Contact: Candice Lee, 415-600-1155, Email: LeeCL@cpmcri.org about Study APRON

    Title: Pilot Study of the Safety, Feasibility, and Potential Efficacy of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)
    Decscription: Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)
    Investigator: William Snape, MD
    Eligibility: Subjects with Type 1 or Type 2 diabetes mellitus for at least 2 years
    Status: Active and open to enrollment
    Contact: Candice Lee, 415-600-1155, Email: LeeCL@cpmcri.org about Study GLUMIT-DG

    Back to top

    Barrett's Esophagus

    Title: Wide Area Transepithelial Sample Esophageal Biopsy combined with computer assisted 3-dimensional analysis (WATS) For the Detection of Esophageal Dysplasia: A Prospective, Randomized, Tandem Study
    Decscription: The primary purpose of this clinical trial is to evaluate a new diagnostic test, Wide Area Transepithelial Sample Esophageal Biopsy (WATS) with 3-Dimensional computer assisted method of analysis, as an adjunct in the detection of esophageal dysplasia
    Investigator: Lauren Gerson, MD
    Eligibility: Subjects, 18 years of age and older, who have a history of Barrett's esophagus (with or without dysplasia of either indefinite, low grade or high-grade)
    Status: Active and open to enrollment
    Contact: Ben Luna, 415-600-3786, Email: LunaB@cpmcri.org about Study WATS

    • updated February 2014

    Back to top